KZR KEZAR LIFE SCIENCES INC Delisting Actions 8-K Filing 2024 - Delisting Kezar Life Sciences, Inc. received a letter from Nasdaq stating that its common stock has closed below $1.00 per share for 30 consecutive business days, but the company has been approved to transfer to the Nasdaq Capital Market and has until November 25, 2024 to regain compliance.Get access to all SEC 8-K filings of the KEZAR LIFE SCIENCES INC